Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis
Deepak Kumar Kaushik, … , Jong M. Rho, V. Wee Yong
Deepak Kumar Kaushik, … , Jong M. Rho, V. Wee Yong
Published May 21, 2019
Citation Information: J Clin Invest. 2019;129(8):3277-3292. https://doi.org/10.1172/JCI124012.
View: Text | PDF
Research Article Autoimmunity Metabolism

Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis

  • Text
  • PDF
Abstract

The migration of leukocytes into the CNS drives the neuropathology of multiple sclerosis (MS). It is likely that this penetration utilizes energy resources that remain to be defined. Using the experimental autoimmune encephalomyelitis (EAE) model of MS, we determined that macrophages within the perivascular cuff of postcapillary venules are highly glycolytic, as manifested by strong expression of lactate dehydrogenase A (LDHA), which converts pyruvate to lactate. These macrophages expressed prominent levels of monocarboxylate transporter-4 (MCT-4), which is specialized in the secretion of lactate from glycolytic cells. The functional relevance of glycolysis was confirmed by siRNA-mediated knockdown of LDHA and MCT-4, which decreased lactate secretion and macrophage transmigration. MCT-4 was in turn regulated by EMMPRIN (also known as CD147), as determined through coexpression and co-IP studies and siRNA-mediated EMMPRIN silencing. The functional relevance of MCT-4–EMMPRIN interaction was confirmed by lower macrophage transmigration in culture using the MCT-4 inhibitor α-cyano-4-hydroxy-cinnamic acid (CHCA), a cinnamon derivative. CHCA also reduced leukocyte infiltration and the clinical severity of EAE. Relevance to MS was corroborated by the strong expression of MCT-4, EMMPRIN, and LDHA in perivascular macrophages in MS brains. These results detail the metabolism of macrophages for transmigration from perivascular cuffs into the CNS parenchyma and identify CHCA and diet as potential modulators of neuroinflammation in MS.

Authors

Deepak Kumar Kaushik, Anindita Bhattacharya, Reza Mirzaei, Khalil S. Rawji, Younghee Ahn, Jong M. Rho, V. Wee Yong

×

Figure 2

Glycolysis drives proinflammatory activities of macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Glycolysis drives proinflammatory activities of macrophages.
(A) Live/de...
(A) Live/dead assay as measured by calcein AM (live cells; gray) and PI (dead cells; red) staining of LPS-stimulated BMDMs in the presence of FX11. Results are representative of 3 independent experiments run in quadruplicate. (B) Graph represents lactate levels in LPS-stimulated or untreated cells in the presence or absence of FX11. (C) ECAR measurement in FX11-treated and untreated inflammatory BMDMs. Results are representative of 2 independent experiments run in quadruplicate; values were normalized to micrograms of protein. (D) Graphs depict glycolysis (mean ECAR upon addition of glucose) and glycolytic capacity (mean ECAR upon addition of oligomycin). Values were normalized to micrograms of protein (n = 4). (E) The effects of FX11 on macrophage transmigration were studied by plating the BMDMs in Transwell inserts (Boyden chambers) in the presence of medium with 1% FBS in the upper chamber and 10% FBS medium in the lower chamber (schematic). Representative images of the transmigrated cells are shown. Scale bar: 50 μm (original magnification, ×30 for insets). The assay was performed in quadruplicate, and the results are representative of 2 independent experiments. (F) Graph represents the average number of cells that migrated over an 8-hour period in the presence or absence of FX11. (G) TNF-α ELISA and (H) Luminex analysis of chemokines revealed a significant reduction in MCP-1 (also known as CCL2) and (I) IP-10 (also known as CXCL10) upon treatment with FX11 in LPS-stimulated cells. All graphs show the mean ± SD (n = 3 unless otherwise indicated). Means were compared using a 2-tailed Student’s t test (D) or 1-way ANOVA with Tukey’s post hoc test (for multiple groups in B, F, and G–I). **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts